Goldman Sachs’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
|
|||||
|
2025
Q1 | $16.7M | Sell |
|
|||||
|
2024
Q4 | $19.2M | Sell |
|
|||||
|
2024
Q3 | $21.9M | Buy |
|
|||||
|
2024
Q2 | $19M | Sell |
|
|||||
|
2024
Q1 | $19M | Buy |
|
|||||
|
2023
Q4 | $18.7M | Sell |
|
|||||
|
2023
Q3 | $17.7M | Sell |
|
|||||
|
2023
Q2 | $18.1M | Buy |
|
|||||
|
2023
Q1 | $18.5M | Buy |
|
|||||
|
2022
Q4 | $18M | Buy |
|
|||||
|
2022
Q3 | $14.1M | Sell |
|
|||||
|
2022
Q2 | $15.4M | Sell |
|
|||||
|
2022
Q1 | $20M | Hold |
|
|||||
|
2021
Q4 | $23.4M | Hold |
|
|||||
|
2021
Q3 | $25M | Buy |
|
|||||
|
2021
Q2 | $23.5M | Sell |
|
|||||
|
2021
Q1 | $21M | Buy |
|
|||||
|
2020
Q4 | $11.8M | Buy |
|
|||||
|
2020
Q3 | $8.1M | Hold |
|
|||||
|
2020
Q2 | $8.15M | Hold |
|
|||||
|
2020
Q1 | $6.4M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $426K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $1.3M | Sell |
|
|||||
|
2017
Q2 | $1.81M | Sell |
|
|||||
|
2017
Q1 | $8.56M | Buy |
|
|||||
|
2016
Q4 | $6.13M | Sell |
|
|||||
|
2016
Q3 | $11.7M | Buy |
|
|||||
|
2016
Q2 | $10.4M | Sell |
|
|||||
|
2016
Q1 | $13.6M | Sell |
|
|||||
|
2015
Q4 | $16.7M | Sell |
|
|||||
|
2015
Q3 | $153M | Buy |
|
|||||
|
2015
Q2 | $162M | Buy |
|
|||||
|
2015
Q1 | $139M | Buy |
|
|||||
|
2014
Q4 | $74.5M | Buy |
|
|||||
|
2014
Q3 | $32.9M | Buy |
|
|||||
|
2014
Q2 | $14.4M | Sell |
|
|||||
|
2014
Q1 | $16.1M | Buy |
|
|||||
|
2013
Q4 | $4.53M | Sell |
|
|||||
|
2013
Q3 | $4.38M | Sell |
|
|||||
|
2013
Q2 | $4.3M | Buy |
|